SCHEMBL4995528

SCHEMBL4995528

Cl[Pt].c1ccc(-c2cccnc2-c2ccccn2)nc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.50
LMNA P02545 3/20 0.50
CCR1 P32246 3/20 0.50
CCR5 P51681 3/20 0.50
CCR8 P51685 3/20 0.50
BLM P54132 2/20 0.50
CYP1A2 P05177 1/20 0.50
POLB P06746 1/20 0.50
METAP1 P53582 1/20 0.50
HIF1A Q16665 1/20 0.50
DOHH Q9BU89 1/20 0.50
P4HTM Q9NXG6 1/20 0.50
TP53 P04637 3/20 0.43
TDP1 Q9NUW8 3/20 0.43
NPC1 O15118 3/20 0.43
ALOX15 P16050 2/20 0.43
HTT P42858 2/20 0.43
SMN1; SMN2 Q16637 2/20 0.43
L3MBTL1 Q9Y468 2/20 0.43
RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30031 0.94 KDM4E (0.56) KDM4ELMNACCR1CCR5CCR8
SCHEMBL3924522 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL16241838 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
Hydrochloric Acid SCHEMBL932365 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL16241819 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL78140 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL933820 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL15436287 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL1652383 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8
SCHEMBL319436 0.92 KDM4E (0.54) KDM4ELMNACCR1CCR5CCR8

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12006334-B2 Alkynylplatinum (II) terpyridine system coupled with rhodamine derivative: interplay of aggregation, de-aggregation and ring-opening processes for ratiometric luminescence sensing SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) 2024-06-11 US disclosed
US-20210002312-A1 ALKYNYLPLATINUM (II) TERPYRIDINE SYSTEM COUPLED WITH RHODAMINE DERIVATIVE: INTERPLAY OF AGGREGATION, DE-AGGREGATION AND RING-OPENING PROCESSES FOR RATIOMETRIC LUMINESCENCE SENSING SOUTH UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA (CN) 2021-01-07 US disclosed
US-8309304-B2 composition for detecting and/or characterizing a multiple-charged biomolecule comprising a charged d8 or d10 metal complex, wherein the metal complex electrostatically binds to the multiple-charged biomolecule to induce aggregation and self-assembly of the metal complex through metal-metal interactions, THE UNIVERSITY OF HONG KONG (CN) 2012-11-13 US disclosed
US-20080153103-A1 Label-Free Optical Sensing and Characterization of Biomolecules by D8 or D10 Metal Complexes UNIVERSITY OF HONG KONG, THE (HK) 2008-06-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210002312-A1 ALKYNYLPLATINUM (II) TERPYRIDINE SYSTEM COUPLED WITH RHODAMINE DERIVATIVE: INTERPLAY OF AGGREGATION, DE-AGGREGATION AND RING-OPENING PROCESSES FOR RATIOMETRIC LUMINESCENCE SENSING TRRAP, TARDBP, TPR KDM4E 4083/4885LMNA 2866/4885CCR1 4740/4885
US-12006334-B2 Alkynylplatinum (II) terpyridine system coupled with rhodamine derivative: interplay of aggregation, de-aggregation and ring-opening processes for ratiometric luminescence sensing TRRAP, TARDBP, TPR KDM4E 4083/4885LMNA 2866/4885CCR1 4740/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.